CELU vs BIIB: Which Stock is Better?
Side-by-side comparison of Celularity Inc and Biogen Inc in 2026
CELU
Celularity Inc
—
BIIB
Biogen Inc
$199.71
Key Metrics Comparison
| Metric | CELU | BIIB | Winner |
|---|---|---|---|
| Market Cap | $25.25M | $29.33B | BIIB |
| P/E Ratio | N/A | 21.39 | BIIB |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CELU
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CELU or BIIB a better investment?
Comparing CELU and BIIB: Celularity Inc has a market cap of $25.25M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CELU and BIIB?
CELU (Celularity Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CELU or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CELU or BIIB?
Both CELU and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CELU or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CELU or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $25.25M for CELU.
Should I buy CELU or BIIB in 2026?
Both CELU and BIIB have investment merit. CELU trades at $N/A while BIIB trades at $199.71. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CELU and BIIB stock?
Key differences: Market Cap ($25.25M vs $29.33B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CELU or BIIB in 2026?
The choice between CELU and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CELU and BIIB?
CELU (Celularity Inc) has a market cap of $25.25M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.